Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT

Aprea Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.4 -1.19 -0.00 -1.67
PEG Ratio
0.03 0.01 -0.00 0.05
PS Ratio
12.06 29.15 n/a n/a
PB Ratio
0.94 0.93 0.02 1.23
P/FCF Ratio
-1.34 -1.39 -0.02 -1.62
P/OCF Ratio
-1.34 -1.4 -0.02 -1.62
OCF/S Ratio
-9.02 -20.88 n/a n/a
Debt / Equity Ratio
n/a n/a n/a 0.00
Quick Ratio
7.01 5.14 9.42 7.73
Current Ratio
7.01 5.14 9.42 7.73
Asset Turnover
0.06 0.03 n/a n/a
Interest Coverage
n/a n/a -83.3 n/a
Return on Equity
-0.67 -0.78 -8.77 -0.74
Return on Assets
-0.54 -0.63 -7.46 -0.64
Return on Invested Capital
-0.69 -0.85 -2.77 -0.74
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.99 0.99 n/a n/a
Net Profit Margin
-8.62 -24.5 n/a n/a
Pretax Profit Margin
-8.62 -24.5 n/a n/a
Operating Profit Margin
-9.53 -26.53 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-8.61 -24.48 n/a n/a